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Introduction {#sec005}
============

Sleep disorders are the most common complaints during menopause transition and postmenopause; these disorders include trouble falling asleep, waking up several times during the night, and waking up earlier than desired in the morning \[[@pone.0192934.ref001],[@pone.0192934.ref002]\]. Poor sleep quality and inadequate sleep duration are associated with negative health outcomes, such as obesity, cardiovascular disease, cancer-related mortality, diabetes, depression, and poor quality of life\[[@pone.0192934.ref003]--[@pone.0192934.ref009]\].Therefore, it is necessary to understand sleep disorders and to identify related risk factors in menopausal women.

Several studies show that perimenopausal and postmenopausal women are more likely to report sleep disturbance than premenopausal women\[[@pone.0192934.ref010]--[@pone.0192934.ref012]\]. For example, a study in a large sample of Colombian women found that sleep problems in middle-aged women were associated with the severity of menopausal symptoms, tobacco use, and the presence of hypertension\[[@pone.0192934.ref009]\].Significant risk factors for sleep disturbance among middle-aged Chinese women include menopause status and menopausal symptoms, in addition to older age and a history of chronic disease\[[@pone.0192934.ref010]\].Age, menopause and related symptoms, perceived stress, mood problems, and hypertension have been identified as potential risk factors for sleep disturbance\[[@pone.0192934.ref013]--[@pone.0192934.ref016]\].

Despite these findings, it may be difficult to determine which factors influence sleep disturbance in menopausal women. Although hormonal changes during menopause influence sleep-related complaints, other factors may also play a significant role\[[@pone.0192934.ref001]\].In particular, sleep disturbance is known to interact with menopausal symptoms, especially vasomotor symptoms\[[@pone.0192934.ref017],[@pone.0192934.ref018]\].A study investigating the relationship between sleep quality and menopausal symptoms found that poorer sleep quality was positively associated with higher rates of somatic and psychological symptoms, and menopausal symptoms were more common in women with frequent sleep complaints than those with infrequent sleep complaints\[[@pone.0192934.ref009],[@pone.0192934.ref018]\].

Although menopausal symptoms have been associated with sleep disturbance, previous studies have focused on vasomotor symptoms. In addition, few studies have investigated the associations between the psychosocial, physical and sexual menopausal symptoms and sleep quality. Therefore, this study investigated the relationship between menopausal symptoms and self-reported sleep quality in middle-aged women.

Materials and methods {#sec006}
=====================

Study participants {#sec007}
------------------

We have used data from the Kangbuk Samsung Health Study. It is a cohort study of South Korean men and women aged 18 years or older who underwent a comprehensive annual or biennial health examination at the clinics of the Kangbuk Samsung Hospital Total Healthcare Center in Seoul and Suwon, South Korea. This cross-sectional observational study was designed to investigate the attitudes of Korean women towards menopause. In total, 2,204 middle-aged women aged 44 to 56 years who visited a healthcare center between November 2012 and March 2013 was selected and the participation rate was about 71%. Subjects who were diagnosed with or were being treated for serious illnesses such as cancer were excluded at the screening stage. The details of the present cohort have been described elsewhere \[[@pone.0192934.ref019]\].The association between sleep quality and menopausal symptoms was investigated in 950 participants who completed a sleep questionnaire. Of these, 171 subjects with a history of hormone replacement therapy for the management of menopausal symptoms, and 145 with missing data on the Menopause-specific Quality of Life (MENQOL)questionnaire were excluded from analysis. Therefore, 634 women were eligible for this study. The study was approved by the Institutional Review Board of Kangbuk Samsung Hospital (IRB No. KBC12156).Written informed consent was obtained from all subjects prior to participation in this study.

Measurements {#sec008}
------------

Body mass index (BMI) was calculated as body weight in kilograms divided by the square of height in meters. Waist circumference (WC) was measured at the midpoint between the lower ribs and the top of the iliac crest in the standing position. Blood pressure (BP) was measured three times using a Welch Allyn sphygmomanometer after a 5min rest period, and the final systolic and diastolic BP were each calculated from two measurements.

Smoking status was categorized as non-current or current. Marital status was categorized as living without or with a partner. Family income was classified as \< 4 million won and\> 4 million won per month. Educational level was categorized as high school or lower, or college/university. Working status was categorized as employed or unemployed. Parity was characterized as 1--2 children and 3 or more children.

Depressive symptoms were assessed using the Korean version of the Center for Epidemiologic Studies Depression Scale (CES-D);CES-D scores≥ 16 were regarded as indicating depressive symptoms\[[@pone.0192934.ref020],[@pone.0192934.ref021]\].

Perceived stress was measured using the stress questionnaire for Korean National Health and Nutrition Examination Survey (KNHANES) \[[@pone.0192934.ref022]\]. Higher scores indicate a higher level of stress.

Menopausal status was defined using the Stages of Reproductive Aging Workshop(STRAW) criteria. Women having regular menstrual periods were defined as premenopausal; those with persistent differences of more than 7 days in the length of consecutive cycles or amenorrhea lasting more than 60 days were regarded as perimenopausal; and women with at least 12 months of amenorrhea classified as postmenopausal\[[@pone.0192934.ref023]\].

Menopausal symptoms {#sec009}
-------------------

The MENQOL questionnaire was used to assess menopause-related symptoms. The 29-item MENQOL is divided into four scales, assessing vasomotor (three items), psychosocial (seven items), physical (16 items) and sexual (three items) domains, with the score on each item ranging from 1 (not experiencing a symptom) to 8 (extremely bothered)\[[@pone.0192934.ref024]\].

Sleep quality assessment {#sec010}
------------------------

The Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire that measures sleep quality during the previous month\[[@pone.0192934.ref025]\]. It consists of 19 items, grouped into seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleeping medication, and daytime dysfunction. Each item has a score ranging from 0 to 3; the seven component scores are summed to yield a global PSQI score, which ranges from 0 to 21. Sleep quality was categorized as good (PSQI≤5) or poor (PSQI\>5), with higher PSQI scores indicating poorer sleep quality.

Statistical analysis {#sec011}
--------------------

Data were expressed as mean ± standard deviation (SD) or number (%).Normal distribution was tested using the Shapiro-Wilk test, and the data is normally distributed. Differences between groups were compared using independent t-tests for parametric data, and non-parametric data compared using the Mann-Whitney *U* test or Kruskal-Wallis test. Categorical variables were compared using the chi-square test. Multiple linear regression analysis was performed to assess the relationship between MENQOL scores and PSQI scores after adjustments for age, BMI, hypertension, diabetes, smoking, marital status, family income, education, employment status, parity, physical activity, depression symptoms, perceived stress and menopausal status. *P-*values \<0.05 were considered statistically significant. All data were analyzed using SPSS Statistics 22 (SPSS Inc., IBM Corp., Chicago, IL, USA).

Results {#sec012}
=======

Characteristics of the study population {#sec013}
---------------------------------------

The demographic characteristics of the study participants are shown in [Table 1](#pone.0192934.t001){ref-type="table"}. The mean age of the participants was48.3±3.3 years, and their mean BMI was 23.1±3.1 kg/m^2^.The mean PSQI score among all subjects was 3.6±2.3, and 19.4% of the subjects reported poor sleep quality(PSQI score \>5). The rates of poor sleep quality in premenopausal, perimenopausal, and postmenopausal women were 14.4%, 18.2%, and 30.2%, respectively. Diastolic BP, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglyceride (TG) levels were significantly higher in subjects with poor sleep quality. Compared with women with good sleep quality, those with poor sleep quality were slightly older, non-smokers, more likely to be living without a partner, less educated, and more likely to have depressive symptoms and higher level of stress.

10.1371/journal.pone.0192934.t001

###### Demographic characteristics of the study population.
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  ------------------------------------------------------------------------------------------------------------------------------------
  Variables                                    Total\      PSQI     *P*-value                                                
                                               (n = 634)                                                                     
  -------------------------------------------- ----------- -------- ----------- -------- ----- -------- --------- --- ------ ---------
  Age, years                                   48.3        ±        3.3         48.1     ±     3.2      49.2      ±   3.6    0.003

  BMI, kg/m^2^                                 23.1        ±        3.1         23.0     ±     3.0      23.5      ±   3.2    0.093

  WC, cm                                       79.0        ±        7.9         78.6     ±     7.8      80.3      ±   8.0    0.036

  SBP (mmHg)                                   105.1       ±        13.3        104.8    ±     13.3     106.3     ±   13.0   0.268

  DBP (mmHg)                                   68.3        ±        10.0        67.8     ±     10.1     70.3      ±   9.7    0.014

  FPG (mg/dL)                                  95.4        ±        15.4        95.2     ±     15.9     96.3      ±   13.4   0.458

  TC (mg/dL)                                   200.7       ±        33.0        199.2    ±     31.4     206.9     ±   38.3   0.040

  HDL-C (mg/dL)                                64.2        ±        14.9        64.5     ±     15.0     63.0      ±   14.8   0.341

  LDL-C (mg/dL)                                122.0       ±        30.3        120.5    ±     28.7     128.0     ±   35.8   0.032

  TG (mg/dL)                                   93.1        ±        52.3        90.9     ±     49.6     102.3     ±   61.3   0.029

  Smoking, n (%)                               16          (3.3)    10          (2.5)    6     (7.0)    0.037                

  Marital status, n (%)                                                                                 0.003                

    Never-married/separated/divorced/widowed   55          (8.8)    36          (7.1)    19    (15.7)                        

    Married/cohabitating                       572         (91.2)   470         (92.9)   102   (84.3)                        

  Family income, n (%)                                                                                  0.046                

    Less than 4 million won                    67          (12.5)   48          (11.1)   19    (18.3)                        

    More than 4 million won                    471         (87.5)   386         (88.9)   85    (81.7)                        

  Education, n (%)                                                                                      \<0.001              

    High school or lower                       205         (33.3)   145         (29.1)   60    (50.8)                        

    College/university                         411         (66.7)   353         (70.9)   58    (49.2)                        

  Employment status                                                                                     0.654                

    Yes                                        271         (46.9)   222         (47.3)   49    (45.0)                        

    No                                         307         (53.1)   247         (52.7)   60    (55.0)                        

  Parity, n (%)                                                                                         0.721                

    1--2                                       495         (80.9)   399         (80.6)   96    (82.1)                        

    ≥ 3                                        117         (19.1)   96          (19.4)   21    (17.9)                        

  Physical activity                                                                                     0.206                

    Low                                        361         (57.0)   283         (55.5)   78    (63.4)                        

    Moderate                                   201         (31.8)   170         (33.3)   31    (25.2)                        

    High                                       71          (11.2)   57          (11.2)   14    (11.4)                        

  Depressive symptoms (CES-D)                                                                           \<0.001              

    \< 16                                      529         (89.1)   444         (92.9)   85    (73.3)                        

    ≥ 16                                       65          (10.9)   34          (7.1)    31    (26.7)                        

  Perceived stress scores                      17.4        ±        16.7        14.5     ±     14.6     28.9      ±   19.3   \<0.001

  Menopausal status                                                                                     \<0.001              

  Premenopause                                 271         (42.7)   232         (45.4)   39    (31.7)                        

  Perimenopause                                214         (33.8)   175         (34.2)   39    (31.7)                        

  Postmenopause                                149         (23.5)   104         (20.4)   45    (36.6)                        

  Total MENQOL score                           2.8         ±        1.26        2.6      ±     1.15     3.5       ±   1.40   \<0.001

  Total PSQI score                             3.6         ±        2.29        2.7      ±     1.33     7.3       ±   1.61   \<0.001
  ------------------------------------------------------------------------------------------------------------------------------------

Data are expressed as mean ± standard deviation or number (%).

Between group comparisons of continuous variables were analyzed by independent sample *t*-tests, and comparisons of categorical variables by chi-square tests.

BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride CES-D, the Center for Epidemiology Studies Depression scale; MENQOL, Menopause-specific Quality of Life; PSQI, Pittsburgh Sleep Quality Index

Total PSQI and subscale scores {#sec014}
------------------------------

[Table 2](#pone.0192934.t002){ref-type="table"} presents the total PSQI and subscale scores according to menopausal status. Total PSQI scores were significantly higher in postmenopausal than in premenopausal women(4.14±2.50 vs. 3.26±2.03,*P* = 0.002). Several of the PSQI subscale scores, specifically sleep latency, habitual sleep efficiency and sleep disturbances scores, also differed significantly according to menopausal status. Sleep duration was the most highly rated of all items, but did not differ significantly among the three menopausal stages.

10.1371/journal.pone.0192934.t002

###### Total Pittsburgh Sleep Quality Index (PSQI) and subscale scores according to menopausal status.
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  PSQI items                  Menopausal status   *P*-value                                              
  --------------------------- ------------------- ----------- ------ ------ --- ------ ------ --- ------ -------
  Subjective sleep quality    0.40                ±           0.59   0.41   ±   0.60   0.51   ±   0.64   0.160
  Sleep latency               0.56                ±           0.78   0.65   ±   0.85   0.86   ±   0.89   0.001
  Sleep duration              1.08                ±           0.65   1.21   ±   0.75   1.15   ±   0.70   0.220
  Habitual sleep efficiency   0.11                ±           0.42   0.14   ±   0.49   0.24   ±   0.61   0.040
  Sleep disturbances          0.57                ±           0.50   0.68   ±   0.55   0.70   ±   0.47   0.018
  Use of sleep medication     0.00                ±           0.06   0.02   ±   0.17   0.05   ±   0.36   0.122
  Daytime dysfunction         0.54                ±           0.66   0.58   ±   0.73   0.62   ±   0.68   0.475
  Total PSQI score            3.26                ±           2.03   3.69   ±   2.37   4.14   ±   2.50   0.002

Data are expressed as mean ± standard deviation and compared by Kruskal-Wallis tests.

Higher total PSQI and subscale scores indicate poorer quality of sleep.

Correlation between MENQOL and PSQI scores {#sec015}
------------------------------------------

[Table 3](#pone.0192934.t003){ref-type="table"} shows correlations between MENQOL and PSQI scores. MENQOL subscale scores showed significant correlations with total PSQI score (P\<0.001). Vasomotor symptom correlated positively with all items on the PSQI, and the association was strongest with sleep disturbances (r = 0.243, P\<0.001). All PSQI items except habitual sleep efficiency were significantly associated with psychosocial symptoms. Physical symptom correlated positively with all PSQI items except habitual sleep efficiency and use of sleep medication. Among all PSQI items, subjective sleep quality had the highest correlation with psychosocial (r = 0.291, P\<0.001) and physical symptoms (r = 0.261, P\<0.001). Overall, sexual symptom had the lowest correlation coefficient of all PSQI items. The correlation between MENQOL and PSQI scores by menopausal status was showed in [S1 Table](#pone.0192934.s001){ref-type="supplementary-material"}.

10.1371/journal.pone.0192934.t003

###### Correlations between MENQOL subscale scores and PSQI (total and subscale) scores.
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  PSQI items                  MENQOL                                                                                                                                       
  --------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ----------------------------------------------
  Subjective sleep quality    0.145[\*\*](#t003fn002){ref-type="table-fn"}   0.291[\*\*](#t003fn002){ref-type="table-fn"}   0.261[\*\*](#t003fn002){ref-type="table-fn"}   0.141[\*\*](#t003fn002){ref-type="table-fn"}
  Sleep latency               0.231[\*\*](#t003fn002){ref-type="table-fn"}   0.208[\*\*](#t003fn002){ref-type="table-fn"}   0.227[\*\*](#t003fn002){ref-type="table-fn"}   0.116[\*](#t003fn001){ref-type="table-fn"}
  Sleep duration              0.099[\*](#t003fn001){ref-type="table-fn"}     0.095[\*](#t003fn001){ref-type="table-fn"}     0.119[\*](#t003fn001){ref-type="table-fn"}     0.077
  Habitual sleep efficiency   0.110[\*](#t003fn001){ref-type="table-fn"}     0.061                                          0.058                                          0.023
  Sleep disturbances          0.243[\*\*](#t003fn002){ref-type="table-fn"}   0.209[\*\*](#t003fn002){ref-type="table-fn"}   0.249[\*\*](#t003fn002){ref-type="table-fn"}   0.143[\*\*](#t003fn002){ref-type="table-fn"}
  Use of sleep medication     0.080[\*](#t003fn001){ref-type="table-fn"}     0.088[\*](#t003fn001){ref-type="table-fn"}     0.029                                          0.048
  Daytime dysfunction         0.140[\*\*](#t003fn002){ref-type="table-fn"}   0.263[\*\*](#t003fn002){ref-type="table-fn"}   0.243[\*\*](#t003fn002){ref-type="table-fn"}   0.078[\*](#t003fn001){ref-type="table-fn"}
  Total PSQI score            0.260[\*\*](#t003fn002){ref-type="table-fn"}   0.334[\*\*](#t003fn002){ref-type="table-fn"}   0.328[\*\*](#t003fn002){ref-type="table-fn"}   0.160[\*\*](#t003fn002){ref-type="table-fn"}

\**P*\<0.05

\*\**P*\<0.001.

Association between menopausal symptoms and sleep quality {#sec016}
---------------------------------------------------------

[Table 4](#pone.0192934.t004){ref-type="table"} shows the results of multiple linear regression analysis of the relationship between menopausal symptoms and sleep quality. Higher PSQI score was positively associated with higher vasomotor (ß = 0.240, *P* = 0.020) and physical (ß = 0.572, *P*\<0.001) scores on the MENQOL, after adjustment for age, BMI, hypertension, diabetes, smoking, marital status, family income, education, employment status, parity, physical activity, depression symptoms, perceived stress and menopausal status. Of the four MENQOL domains, physical score showed the strongest positive association with total PSQI score. However, no association were observed between psychosocial and sexual score and total PSQI score. The overall regression model for the MENQOL subscale scores explained 28.2 percent of the variance in Total PSQI score.

10.1371/journal.pone.0192934.t004

###### Multiple linear regression analysis of the relationship between MENQOL subscale scores and total PSQI score.
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  MENQOL                  Total PSQI score                      
  -------------- -------- ------------------ -------- --------- -------
  Vasomotor      0.240    0.103              0.146    0.020     0.282
  Psychosocial   -0.118   0.147              -0.074   0.422     
  Physical       0.572    0.153              0.307    \<0.001   
  Sexual         -0.131   0.075              -0.105   0.082     

Beta coefficients and *P*-values are presented.

Adjusted for age, body mass index, hypertension, diabetes, smoking, marital status, family income, education, employment status, parity, physical activity, depression symptoms (CES-D), perceived stress symptoms and menopausal status.

Discussion {#sec017}
==========

The present study examined the relationship between self-reported menopausal symptoms and sleep quality in healthy women aged 44--56 years, after controlling for potential confounders. Total PSQI score and subscores for sleep latency, habitual sleep efficiency and sleep disturbances differed significantly according to menopausal status. Poor sleep quality was related with vasomotor and physical menopausal symptoms but not with psychosocial and sexual symptoms. In particular, physical symptom showed the strongest association with sleep quality.

The prevalence of poor sleep quality differs among ethnic groups, being lower in Asian populations\[[@pone.0192934.ref011]\]. A cross-sectional study found that almost 40% of women aged 40--55 years reported sleep difficulty, as assessed by a single question on sleep difficulty; however ethnicity-stratified results showed that Caucasian women (40.3%) had the highest rate of sleep difficulty, and Japanese (28.2%) and Chinese (31.6%) women had the lowest rates\[[@pone.0192934.ref011]\]. Results from a community-based sample in Hong Kong found that about 26% of the women were poor sleepers as defined by a PSQI score \> 5\[[@pone.0192934.ref026]\]. A large scale cross-sectional study reported that 18.1% of Chinese women aged 45--65 years suffered from insomnia\[[@pone.0192934.ref027]\]. Consistent with previous findings, our results showed that about 19% of the women reported poor sleep quality, and that poor sleep quality was more common in postmenopausal (30.2%) than in premenopausal women (14.4%).

Most earlier studies found that menopausal status was significantly associated with poor sleep quality\[[@pone.0192934.ref011],[@pone.0192934.ref014],[@pone.0192934.ref026]\]. In particular, a previous study in Korea found that insomnia was significantly associated with the menopausal transition\[[@pone.0192934.ref028]\].Our results showed that the prevalence of poor sleep quality was significantly higher in postmenopausal than in premenopausal women. In addition, total PSQI score increased according to menopause status, as did several PSQI items, including sleep latency, habitual sleep efficiency and sleep disturbances.

In addition to menopausal status, we found that poor sleep quality was highly prevalent in women with lower education and income levels. These findings were consistent with results showing that the rate of sleep disturbance among middle-aged women decreased with increasing education and income levels \[[@pone.0192934.ref010],[@pone.0192934.ref029]\].Therefore, our results may indicate that higher education and income levels had a favorable influence on the sleep quality.

Previous studies also report associations between menopausal symptoms and sleep disturbances \[[@pone.0192934.ref009],[@pone.0192934.ref010],[@pone.0192934.ref018]\]. Our study found that women with higher total MENQOL and subscale scores had higher total PSQI scores, indicating that women with more severe menopausal symptoms experienced poorer sleep quality. Interestingly, our multiple linear regression models showed that vasomotor and physical symptoms, but not psychosocial and sexual symptoms, on the MENQOL were significantly related to sleep quality after adjusting for confounding factors, independent of menopause status. Of the four MENQOL domains, physical symptoms showed the highest correlation with sleep quality. In multiple linear regression analysis of [Table 4](#pone.0192934.t004){ref-type="table"}, the income (ß = 1.045, *P* = 0.004), education (ß = -1.106, *P*\<0.001), and depression symptoms (ß = 0.065, *P* = 0.002) were significantly associated with the overall PSQI. This might be influenced sleep disturbance. Consistent with our findings, previous studies in middle-aged women showed that sleep problems were associated with somatic and psychological menopausal symptoms\[[@pone.0192934.ref009],[@pone.0192934.ref026]\]. In addition, a cross-sectional study of postmenopausal women attending a menopause clinic found that vasomotor symptoms were related with various symptoms of sleep disturbance\[[@pone.0192934.ref030]\]. By contrast, a study in middle-aged Chinese women reported no association between vasomotor symptoms and sleep disturbance\[[@pone.0192934.ref026]\].

The causes of sleep disturbance during menopause are unclear, but many factors may be involved, including vasomotor symptoms, changing hormone levels, mood disorders, coexistent medical conditions, and lifestyle factors \[[@pone.0192934.ref031]\].In particular, reduced hormone levels may have a significant impact on sleep disturbance. Studies have shown that hormone replacement therapy improved the sleep quality in peri- and postmenopausal women\[[@pone.0192934.ref032]--[@pone.0192934.ref035]\]. The beneficial effect of hormone therapy may be due to the presence of estrogen and estrogen receptors in the central nervous system, which is involved in sleep regulation\[[@pone.0192934.ref036]--[@pone.0192934.ref037]\].In addition, obesity may have a negative impact on sleep quality, as was shown by results from Finland on postmenopausal women, which reported impaired sleep quality in women with high BMI \[[@pone.0192934.ref018]\]. High BMI predisposes to partial upper-airway obstruction and increased respiratory resistance, which may contribute to poorer sleep quality\[[@pone.0192934.ref038],[@pone.0192934.ref039]\]. Therefore, longitudinal studies are needed to better understand the association between these factors and sleep disturbance. Although our findings require confirmation, they provide evidence regarding the associations between menopausal symptoms and sleep quality in middle-aged women.

To our knowledge, this is one of few studies to evaluate the relationship between menopausal symptoms and sleep quality in Asian women using validated instruments. However, this study had several limitations. First, its cross-sectional design prevented the determination of the causality of the relationship, indicating the need for longitudinal studies to determine the association between menopausal symptoms and sleep quality. Second, our study population consisted of middle-aged healthy women attending a healthcare center. Thus, these results may not be applicable to the entire menopausal population in Korea. Finally, sleep quality and menopausal symptoms were measured using self-reported questionnaires, suggesting the need for objective assessments, such as polysomnography.

Conclusions {#sec018}
===========

Vasomotor and physical menopausal symptoms was related to poor sleep quality. Although further prospective studies are required to better understand these findings, effective management strategies aimed at reducing menopausal symptoms may improve sleep quality.

Supporting information {#sec019}
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